Navigation Links
Strategy in Biological Technology

China Biologic Products Hosts its First Forum for Strategy and Development

TAIAN CITY, China, July 16 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("China Biologic" or the "Company"), one of the leading plasma-based pharmaceutical companies in the People's Republic of China ("PRC"), today announced that the Company hosted a ...

PharmAthene's 2nd Generation rPA Anthrax Vaccine, SparVax(TM), Completes FDA Regulatory Strategy Review

ANNAPOLIS, Md., July 9 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: PIP ), a biodefense company developing medical countermeasures against biological and chemical threats, today announced that the U.S. Food and Drug Administration (FDA) has completed its review of the Company's propos...

Arpida to Discuss Strategy With Shareholders

REINACH, Switzerland, May 7 /PRNewswire-FirstCall/ -- Arpida Ltd. (SIX: ARPN) will today discuss potential strategic scenarios with its shareholders during the Annual General Meeting (AGM) which starts at 10am CET in Reinach, Switzerland. After the negative FDA opinion regarding intrave...

Healthplace America Engages Robert A. Yungk to Provide Services as Chief Strategy Officer

Mr. Yungk to Direct Strategic Development of the Company's National Network of Medical Provider Best Practice Leaders LISLE, Ill., April 7 /PRNewswire/ -- Healthplace America, the country's first and only Surgery Benefit Management(TM) solution company, is engaging the services of Robert A. Y...

Independent Study Corroborates Prana's Strategy to Treat Alzheimer's Disease Patients.

- Journal of Neuroscience paper describes role of Zinc in developing Alzheimer's - MELBOURNE, Australia, April 1 /PRNewswire-FirstCall/ -- Prana Biotechnology (ASX:PBT; Nasdaq: PRAN ) today announced that an independent study conducted by researchers at the University of California, Irvine...

Aethlon Medical Announces Data Supported Strategy to Increase Hepatitis-C (HCV) Cure Rates

SAN DIEGO, March 25 /PRNewswire-FirstCall/ -- Aethlon Medical, Inc. (OTC Bulletin Board: AEMD) today announced clinical data that supports the advancement of the Aethlon Hemopurifier(R) as an adjunct therapy to increase Hepatitis-C (HCV) cure rates. The Hemopurifier(R) is a first-in-class medical ...

Tianyin Pharmaceutical Co., Inc. Adopts New Sales Strategy for Azithromycin Dispersible Tablets

CHENGDU, China, March 17 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical, Co., Inc., (NYSE Alternext: TPI), a manufacturer and supplier of modernized traditional Chinese medicine ("TCM") based in Chengdu, China, today announced it has adopted a new sales strategy for Azithromycin Dispers...

Perceptive Informatics Receives Frost & Sullivan Product Line Strategy Award

BOSTON, Feb. 24 /PRNewswire-FirstCall/ -- Perceptive Informatics, the industry's leading eClinical solutions provider and a subsidiary of PAREXEL International Corporation (Nasdaq: PRXL ), today announced that it has received the Frost & Sullivan Product Line Strategy Award. Frost & Sul...

CFSO Calls for Roundtable to Develop National Strategy for Advancing Forensic Sciences in the United States

DENVER, Feb. 17 /PRNewswire-USNewswire/ -- AAFS Convention -- With tomorrow's release of the Forensics Study by the National Academy of Sciences, The Consortium of Forensic Science Organizations (CFSO) has announced that: -- Peter Marone, CFSO chairman, will be available to the media f...

DuPont Unveils New Strategy to Expand its Seed Business

Pioneer Hi-Bred Partners with Seed Companies to Introduce New Products, Brands. Chicago, IL (Vocus) December 11, 2008 —- DuPont business Pioneer Hi-Bred today unveiled a new business strategy to bring its seed genetics to more acres around the world through a ne...

Lilly Highlights Transformation Strategy for Wall Street, Reviews Robust Pipeline and Sets 2009 Financial Guidance

NEW YORK, Dec. 11 /PRNewswire-FirstCall/ -- -- Innovation and Patient-Centered Approach Expected to Drive Future Success -- Lilly Climbs into Top 10 Pharmaceutical Companies in Worldwide Sales and Is Fastest Growing in U.S. -- FIPNet Strategy Expands Global Reach and...

Tianyin Pharmaceutical Co., Inc. Implements New Sales and Marketing Strategy to Drive Revenue Growth

CHENGDU, China, Dec. 2 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical, Co., Inc., (NYSE EuroNext: TPI), a manufacturer and supplier of modernized traditional Chinese medicine ("TCM") based in Chengdu, China, today announced the implementation of a new sales and marketing strategy to categor...

White Paper Examines New 'Thin LIMS' IT Implementation Strategy for cGMP Quality Informatics

HOPKINTON, Mass., Oct. 20 /PRNewswire/ -- The implementation of a compliant Laboratory Information Management System (LIMS) for the QC/QA laboratory environment is often victimized by "scope creep," with costs rising 2 to 5 times above originals estimates and forcing the continued funding of a...

Solos Endoscopy, Inc. Implements Strategy to Capitalize on $30 Billion Minimally Invasive Surgical Product Market

BOSTON, Sept. 30 /PRNewswire-FirstCall/ -- Solos Endoscopy, Inc. (Pink Sheets: SNDY) is pleased to announce that the Company intends to expand their current industry to include and capitalize on the $30 billion minimally invasive instrumentation market by implementing a business strategy. The ...

WuXi PharmaTech (NYSE:WX) Maintains Original Strategy to Provide Toxicology Services in China

SHANGHAI, China, Sept. 29 /Xinhua-PRNewswire/ -- WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, announced today that it will no longer pursue a 50-50 joint ventu...

Covance Decides to Pursue Its Original Preclinical Strategy in China

PRINCETON, N.J., Sept. 29 /PRNewswire-FirstCall/ -- Covance Inc. (NYSE: CVD) announced today that it will no longer pursue a 50-50 joint venture with WuXi Pharmatech to provide preclinical contract research services in China. "We expect China will become an attractive region for outsourced d...

Sanofi Aventis : New Study Results Support the "Basal Plus" Strategy With LANTUS(R) and APIDRA(R) to Improve Blood Sugar Control in Patients With Type 2 Diabetes

PARIS, September 10 /PRNewswire-FirstCall/ -- - Abstracts 185 and 1112 Sanofi-aventis, a world leader in diabetes care, announced results from two randomized clinical studies presented at the European Association for the Study of Diabetes (EASD) 44th Annual Meeting demonstrating that the "...

Anesiva Announces Conference Call and Webcast to Discuss Updates to Corporate Strategy and Milestones

SOUTH SAN FRANCISCO, Calif., Sept. 2 /PRNewswire-FirstCall/ -- Anesiva, Inc. (Nasdaq: ANSV ) announced that it will hold a conference call and webcast on Wednesday, September 3, 2008 at 11:30 am Eastern time (8:30 am Pacific time). During the call, Anesiva management will update its corporate...

Nicholas J. Hart Joins Emisphere as Vice President, Strategy and Development

Former Organon Exec Will Help Drive Company's Commercialization of Eligen(R) Technology CEDAR KNOLLS, N.J., Aug. 19 /PRNewswire-FirstCall/ -- Emisphere Technologies, Inc. (Nasdaq: EMIS ) has announced that Nicholas J. Hart has joined the company as Vice President of Strategy and Development...

Exiqon Receives the 2008 Frost & Sullivan Growth Strategy Leadership Award

VEDBAEK, Denmark, July 24 /PRNewswire-FirstCall/ -- Frost & Sullivan has announced the selection of Exiqon as the recipient of its 2008 Growth Strategy Leadership Award in the molecular diagnostic market. This award follows Frost & Sullivan's most recent analysis of the molecular diagnostic ma...

GlaxoSmithKline - Q2 Results and Strategy Update - Interview with CEO

LONDON, July 23 /PRNewswire-FirstCall/ -- In a video interview, new CEO Andrew Witty comments on GSK's second quarter results while also updating the market on his strategic vision for the business. The new strategic priorities for GlaxoSmithKline are: - Grow a diversified global busin...

CellCyte Genetics Retains InCap Group to Advise on Business Strategy and Financing

BOTHELL, Wash., July 9 /PRNewswire-FirstCall/ -- CellCyte Genetics Corporation (CellCyte) (OTC Bulletin Board: CCYG) has engaged InCap Group, Inc. (InCap) to provide strategic investment and financial advice and services. CellCyte seeks to build shareholder value by monetizing its two core pla...

Mega-Brand Success: Effective Market Strategy and Tactics

CHAPEL HILL, N.C., June 10 /PRNewswire/ -- Pharmaceutical companies can literally add -- or subtract -- billions of dollars in the lifetime cash flows of potential mega-brands. Research and development groups no longer singularly drive the value of a new product. Sales and Marketing teams also...

American Oriental Bioengineering Appoints Anindya Chatterjee to Chief Strategy Officer

- Anindya Chatterjee Brings Over Thirteen Years of Capital Markets Experience to AOBO - - New Role Emphasizes Strategic Growth Plan and Capital Markets Interaction - NEW YORK, June 9 /PRNewswire-FirstCall/ -- American Oriental Bioen...

Sosei Announces Outcome of Strategy Review

TOKYO, May 14 /PRNewswire-FirstCall/ -- Sosei Group Corporation ("Sosei"; TSE Mothers Index: 4565), a biopharmaceutical company, today announces the outcome of its strategy review. In view of the current market conditions, the difficulty in raising finance at the current low share price, and...

Chindex International Announces Shelf Registration, Related Strategy and Guidance

BETHESDA, Md., May 13 /Xinhua-PRNewswire/ -- Chindex International, Inc. (Nasdaq: CHDX ), a leading independent American provider of Western healthcare services and products in the People's Republic of China, announced that it has filed a shelf registration statement with the Securities and E...

Regenesis Biomedical Advances Corporate Strategy by Appointing Vice President of Marketing

Confirms commitment to accelerating market penetration and revenue growth SCOTTSDALE, Ariz., May 1 /PRNewswire/ -- Regenesis Biomedical, Inc., a medical technology company that markets the Provant(R) Wound Therapy System, announced today that Scott Robey joined the company as Vice President of ...

Scientists develop strategy to rapidly describe outbreak strains with next-generation DNA sequencing

Friday, April 11, 2008 In the event of an outbreak or a bioterrorist attack, rapid identification of the genetic changes responsible for virulence or drug resistance is essential to mounting an effective response. Standard DNA sequencing and analysis of a pathogen genome is time-intensive and li...

Bavarian Nordic Update - 2007 Annual Results, IMVAMUNE(R) Delivery Contract, Strategy Process

WASHINGTON DC, April 2 /PRNewswire-FirstCall/ -- Bavarian Nordic, the Danish-based biopharmaceutical company, recently published its 2007 Annual Report. Below is an extract of the most significant matters in the report as well as events after the balance sheet date. Bavarian Nordic's revenue...

Cardiac Science Unveils Major Brand Change; Strategy to Lift Brand Awareness

BOTHELL, Wash., March 6 /PRNewswire-FirstCall/ -- Cardiac Science Corporation (Nasdaq: CSCX ), a global leader in advanced cardiac diagnosis, resuscitation, rehabilitation, and informatics products, announced today that it aligned the power of its leading product brands (Burdick(R), HeartCent...

Emisphere to Host Business Strategy Conference Call on February 7

- CEO Michael V. Novinski to Discuss Plans for Company in 2008 and Beyond - CEDAR KNOLLS, N.J., Jan. 31 /PRNewswire-FirstCall/ -- Emisphere Technologies, Inc. (Nasdaq: EMIS ), announced today that it will host a teleconference on Thursday, February 7, at 10:00 AM EST. President and Chief Execut...

Co-Inventor of Amgen's Aranesp(R) Technology Directs Worldwide Patent Strategy for Diffusion Pharmaceuticals' First-in-Class Oxygen Enhancing Therapeutics

CHARLOTTESVILLE, Va., Dec. 21 /PRNewswire/ -- Diffusion Pharmaceuticals LLC, a clinical stage drug-development company commercializing first-in-class drugs utilizing a novel mechanism of action that enhances oxygen diffusion, today announced that one of its key advisors, Mr. Thomas Byrne, was ...

Bristol-Myers Squibb Company Outlines Strategy and Productivity Transformation Initiative During Update to Investment Community

* Expects Productivity Transformation Initiative to Generate Pre-Tax Cost Savings and Avoidance of Approximately $1.5 Billion by 2010 and Incur Associated Pre-Tax Costs of $900 Million to $1.1 Billion - Reducing Total Headcount by 10% * Announces 11% Increase in ...

Product Development Timelines and Commercialization Strategy Are Focus of New Group at Premier Research

PHILADELPHIA, Nov. 29 /PRNewswire/ -- As part of an ongoing commitment to help clients reduce product development times and maximize commercial impact of their products, Premier Research Group plc (AIM: PRG) announced today the consolidation of its industry-leading expertise in its core servic...

Orexigen(R) Therapeutics Announces Jay Hagan as Senior Vice President, Corporate Development and Strategy

SAN DIEGO, May 11 /PRNewswire-FirstCall/ -- Orexigen(R) Therapeutics, Inc. (Nasdaq: OREX ), a biopharmaceutical company focused on the treatment of obesity, today announced that Jay Hagan has joined the organization as Senior Vice President of Corporate Development and Strategy. "Jay brin...

Immunotech Laboratories Announces South American Strategy

GLENDALE, Calif., April 3 /PRNewswire-FirstCall/ -- Immunotech Laboratories (Pink Sheets: IMMB) is happy to announce preliminary discussions in setting up a potential venture for South America, headquartered in Mexico. According to Ara Ghanime, Chairman of Immunotech Laboratories, the poten...

Obio Pharmaceutical Announces Product Growth Strategy

HONG KONG, Feb. 18 /PRNewswire-Asia/ -- Obio Pharmaceutical Holdings Ltd ("Obio"/ "the Company") announced its business growth ticket to the international pharmaceutical arena. With a strong product pipeline in drug development, backed up by strong international investors including Yangtze Ven...

Odyssey Thera Granted U.S. Patent for Novel GPCR Assay Strategy

Claims extend and strengthen Odyssey Thera's coverage to include GPCR directed screening and drug profiling. SAN RAMON, Calif., Feb. 12 /PRNewswire/ -- Odyssey Thera, Inc. announced today that it has been granted a United States patent entitled "Fragment Complementation Assays for G-Protein-C...

Panel blasts federal nanotech risk research strategy

Washington, DC A National Research Council (NRC) committee today issued a highly critical report describing serious shortfalls in the Bush administration's strategy to better understand the environment, health and safety (EHS) risks of nanotechnology and to effectively manage those potential risk...

PAREXEL Partners with Glenmark to Win the Good Clinical Practice Journal Award for Most Innovative Patient Recruitment Strategy

BOSTON, Oct. 29 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (Nasdaq: PRXL ), a leading global biopharmaceutical services provider, in partnership with Glenmark Pharmaceuticals Ltd, today announced that it has been recognized by the Good Clinical Practice Journal (GCPj) as the ...
Other Tags
(Date:8/29/2014)... Researchers at UC Davis have made some surprising ... infection. Studying simian immunodeficiency virus (SIV), the team ... Paneth cells are early responders to viral invasion ... producing a cytokine called interleukin-1 beta (IL-1β). ... IL-1β causes breakdown of the gut epithelium that ...
(Date:8/29/2014)... recently, little has been known about what genetic changes ... of scientists, one of whom is a University of ... that genes controlling the development of the brain and ... The study was published Aug. 28 in Science ... is online at http://www.sciencemag.org/ ., The domestication of ...
(Date:8/29/2014)... over the last 120,000 years may have influenced ... researchers led by City College of New York ... metric called "phylogeographic endemism." , It quantifies the ... is restricted in geographical space. , Dr. Carnaval, ... researchers from institutions in Brazil, Australia and the ...
Breaking Biology News(10 mins):The early cost of HIV 2New research reveals how wild rabbits were genetically transformed into tame rabbits 2New research reveals how wild rabbits were genetically transformed into tame rabbits 3CCNY team defines new biodiversity metric 2
(Date:9/1/2014)... Steven Reinberg ... News) -- In a head-to-head comparison, an experimental drug ... and hospitalizations in heart failure patients. According to ... of the marked benefit of the new drug, dubbed ... those getting the standard medication, enalapril (Vasotec), either died ...
(Date:9/1/2014)... An operating theatre or operating room is ... operations. An operating room comprises a myriad of specially-designed ... lights, imaging displays as well as integration systems for ... Research, a U.S.-based market research firm, the operating room ... by 2019. , According to this report, the ...
(Date:9/1/2014)... Barcelona, Spain Monday 1 September 2014: Daily fruit ... up to 40%, according to research presented at ESC ... The findings from the seven year follow-up study of ... found that the more fruit people ate, the more ... "CVD, including ischaemic heart disease (IHD) and stroke, is ...
(Date:9/1/2014)... (PRWEB) September 01, 2014 Bioinformatics ... organize and analyze biological and genetic data. A ... activity of developing software tools to generate and ... be confused with biological computation. While bioinformatics simply ... of biology can its related concepts, biological computation ...
(Date:9/1/2014)... 2014 Ontraport , one of ... was developed to automate the small intricacies of managing ... Shane Michaels, prompting an investigative review. , “As ... of managing all of the small details involved with ... reports Michaels. “That’s why Ontraport has become so popular ...
Breaking Medicine News(10 mins):Health News:Drug Gives 'New Hope' Against Heart Failure, Expert Says 2Health News:Drug Gives 'New Hope' Against Heart Failure, Expert Says 3Health News:Operating Room Equipment Market Study 2019 by Transparency Market Research 2Health News:Operating Room Equipment Market Study 2019 by Transparency Market Research 3Health News:Fruit consumption cuts CVD risk by up to 40 percent 2Health News:Fruit consumption cuts CVD risk by up to 40 percent 3Health News:Bioinformatics Market: A fusion of Computers and Biological Data 2Health News:Bioinformatics Market: A fusion of Computers and Biological Data 3Health News:Bioinformatics Market: A fusion of Computers and Biological Data 4Health News:Ontraport: Review Exposes Automated Platform for Online Marketing Management 2
Other Contents